Viewing Study NCT04767035


Ignite Creation Date: 2025-12-24 @ 10:37 PM
Ignite Modification Date: 2025-12-28 @ 7:27 AM
Study NCT ID: NCT04767035
Status: COMPLETED
Last Update Posted: 2021-02-23
First Post: 2020-11-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine
Sponsor: Melt Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module